211 related articles for article (PubMed ID: 10699300)
21. Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
Camargo JA; Sapin A; Daloz D; Maincent P
J Microencapsul; 2010; 27(7):609-17. PubMed ID: 20695833
[TBL] [Abstract][Full Text] [Related]
22. Formulation and evaluation of verapamil hydrochloride loaded solid lipid microparticles.
Pilaniya U; Pilaniya K; Chandrawanshi HK; Gupta N; Rajput MS
Pharmazie; 2011 Jan; 66(1):24-30. PubMed ID: 21391431
[TBL] [Abstract][Full Text] [Related]
23. Impact of dispersion time interval and particle size on release profiles of propranolol HCl and carbamazepines from microparticle blends system.
Muhaimin M; Chaerunisaa AY; Bodmeier R
Sci Rep; 2022 Jun; 12(1):10360. PubMed ID: 35726009
[TBL] [Abstract][Full Text] [Related]
24. Characterization of protein-loaded poly(epsilon-caprolactone) microparticles based on a factorial design.
Lin WJ; Huang LI; Chang RR
J Microencapsul; 2001; 18(2):183-9. PubMed ID: 11253935
[TBL] [Abstract][Full Text] [Related]
25. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
Huang J; Wigent RJ; Schwartz JB
J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
[TBL] [Abstract][Full Text] [Related]
26. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
27. Polymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: in vitro evaluation.
Zhao L; Wei YM; Yu Y; Zheng WW
Arch Pharm Res; 2010 Mar; 33(3):443-50. PubMed ID: 20361310
[TBL] [Abstract][Full Text] [Related]
28. Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique.
Dinarvand R; Moghadam SH; Sheikhi A; Atyabi F
J Microencapsul; 2005 Mar; 22(2):139-51. PubMed ID: 16019900
[TBL] [Abstract][Full Text] [Related]
29. Influence of pluronics on protein-loaded poly(epsilon-caprolactone) microparticles.
Lin WJ; Huang LI
J Microencapsul; 2001; 18(2):191-7. PubMed ID: 11253936
[TBL] [Abstract][Full Text] [Related]
30. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
31. Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing.
Passerini N; Perissutti B; Albertini B; Voinovich D; Moneghini M; Rodriguez L
J Control Release; 2003 Mar; 88(2):263-75. PubMed ID: 12628333
[TBL] [Abstract][Full Text] [Related]
32. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system.
Zhou S; Deng X; Yang H
Biomaterials; 2003 Sep; 24(20):3563-70. PubMed ID: 12809785
[TBL] [Abstract][Full Text] [Related]
33. Microparticles prepared by grinding of polymeric films.
Elkharraz K; Dashevsky A; Bodmeier R
J Microencapsul; 2003; 20(5):661-73. PubMed ID: 12909549
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
[TBL] [Abstract][Full Text] [Related]
35. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres.
Sansdrap P; Moës AJ
J Microencapsul; 1998; 15(5):545-53. PubMed ID: 9743911
[TBL] [Abstract][Full Text] [Related]
36. Microencapsulation of antimicrobial ceftiofur drugs.
Bodmeier R; Chen H; Davidson RG; Hardee GE
Pharm Dev Technol; 1997 Nov; 2(4):323-34. PubMed ID: 9552461
[TBL] [Abstract][Full Text] [Related]
37. Solid-state characterization of nifedipine solid dispersions.
Vippagunta SR; Maul KA; Tallavajhala S; Grant DJ
Int J Pharm; 2002 Apr; 236(1-2):111-23. PubMed ID: 11891075
[TBL] [Abstract][Full Text] [Related]
38. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
39. Slow-release melarsoprol microparticles.
Gibaud S; Gaia A; Astier A
Int J Pharm; 2002 Aug; 243(1-2):161-6. PubMed ID: 12176304
[TBL] [Abstract][Full Text] [Related]
40. Biodegradable microspheres of novel segmented poly(ether-ester-amide)s based on poly(epsilon-caprolactone) for the delivery of bioactive compounds.
Barbato F; La Rotonda MI; Maglio G; Palumbo R; Quaglia F
Biomaterials; 2001 Jun; 22(11):1371-8. PubMed ID: 11336310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
